When analyzing the SNP-array data four different amplicons in the MYCN region in 2p24 as well as a 17q gain are identified, both of which are predictors of poor prognosis and aggressive disease in neuroblastoma that were not identified with sequencing data alone. This evidence concerns the gene MYCN and neuroblastoma.